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Decoupling manufacturing from application in
additive manufactured antimicrobial materials†
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3D printable materials based on polymeric ionic liquids (PILs)
capable of controlling the synthesis and stabilisation of silver
nanoparticles (AgNPs) and their synergistic antimicrobial activity
are reported. The interaction of the ionic liquid moieties with the
silver precursor enabled the controlled in situ formation and stabil-
isation of AgNPs via extended UV photoreduction after the printing
process, thus demonstrating an effective decoupling of the device
manufacturing from the on-demand generation of nanomaterials,
which avoids the potential aging of the nanomaterials through oxi-
dation. The printed devices showed a multi-functional and tune-
able microbicidal activity against Gram positive (B. subtilis) and
Gram negative (E. coli) bacteria and against the mould Aspergillus
niger. While the polymeric material alone was found to be bacter-
iostatic, the AgNPs conferred bactericidal properties to the
material. Combining PIL-based materials with functionalities, such
as in situ and photoactivated on-demand fabricated antimicrobial
AgNPs, provides a synergistic functionality that could be harnessed
for a variety of applications, especially when coupled to the
freedom of design inherent to additive manufacturing techniques.
Introduction
Antimicrobial resistance is a significant global health chal-
lenge around the world.1 A potential solution that has enjoyed
significant interest are materials with inherent antimicrobial
properties.2 One example is silver nanoparticles (AgNPs),
which exhibit broad antimicrobial potential,3,4 and can be sup-
ported in a wide range of polymers and hydrogels.5–8 Such
materials can be fabricated into myriad functional shapes and
devices by utilising the design freedoms afforded by 3D print-
ing,9 and indeed there are many examples of AgNP supporting
materials that have been 3D printed.10–17 Typically, the AgNPs
are either dispersed in the resin before 3D printing, or the
AgNPs are formed during the 3D printing process, and then
the materials can be used immediately. However, the dis-
advantage to this approach is that it does not allow for tune-
able fabrication of the AgNPs so the efficacy of the device is tai-
lored for the particular application at the point of use.
Therefore, to maintain maximal antimicrobial efficacy,
whilst still allowing for a responsive bespoke personalised
healthcare approach enabled by the inherent freedoms
afforded by 3D printing, decoupling of the manufacture of the
3D printed part and the formation of AgNPs is needed. There
are some examples of 3D printed materials containing AgNPs,
wherein the fabrication is decoupled from the AgNP for-
mation, but they typically require post-printing treatments,
like energy-intensive heating steps,18 or immersion of the
printed part in a reducing solution.19
A desirable alternative is a polymeric matrix that can be 3D
printed, has the required mechanical properties and also
maintains the silver precursor in the oxidised form to enable a
controlled reductive formation of the AgNPs at the point of
need. Fantino et al. have demonstrated on-demand photo-
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reductive formation of AgNPs within photocured polyethylene
glycol diacrylate (PEGDA), which was decoupled from the 3D
printing step. However, their system appeared to offer limited
ability to stabilise AgNPs, and nanoparticle aggregation and
migration were observed.20 One suitable class of materials to
achieve superior stabilisation ability are poly(ionic liquids),
also known as polymeric ionic liquids (PILs), which are poly-
electrolytes,21 formed from polymerisable ionic liquid mono-
mers. PILs possess analogous properties to bulk ionic liquids
in solution,22,23 and also enable exquisite tuning of the
polymer properties through a near-infinite combination of
cations and anions, together with the broad range of architec-
ture and morphology variations inherent to polymeric
materials.24 There are many examples of poly(ionic liquid)
functional materials such as porous electro-optic films,25 ion
conductive polymer films,26–29 dispersants,30 and
actuators.31,32 Furthermore, PILs can also be 3D printed using
a range of techniques, such as inkjet printing,33 DLP,34,35 and
microstereolithography.36 In addition, the ability of ionic
liquids and PILs to stabilise and support metal nanoparticle
precursor salts and nanoparticles has been well demon-
strated.37 Finally, ILs and PILs can be designed so as to
possess inherent broad antimicrobial properties, against bac-
teria and fungi.38–41
Therefore, we propose the use of 3D printable poly(ionic
liquids) to fabricate multifunctional materials that feature
three key properties; (i) on-demand photoreductive formation
of the AgNPs within the material that is decoupled from the
3D printing step; (ii) an antimicrobial effect of the PIL back-
bone; combined with (iii) the broad antimicrobial action
afforded by AgNPs. Vat photopolymerisation is selected as the
3D printing technique for proof of concept, since it allows the
rapid formulation of polymerisation formulations and the
generation of precise, complex geometries.
Herein we report the development of novel 3D-printable
materials based on two different polymeric ionic liquids (PILs)
functionalised with silver nanoparticles (AgNPs), we compare
and contrast the formation and stabilisation of the silver nano-
particles in the two formulations and investigate the anti-
microbial properties. The ability of each PIL to stabilise active
nanomaterials via photoreduction is demonstrated by effective
decoupling of the fabrication from the on-demand generation
of low polydispersity AgNPs by subsequent exposure to UV
irradiation. Furthermore, the tuneable antimicrobial activity of
the AgNP@PIL printed devices against Gram-positive Bacillus
subtilis (B. subtilis) and Gram-negative Escherichia coli (E. coli)
bacteria, and Aspergillus niger (A. niger) and Cladosporium cla-
dosporioides (C. cladosporioides) fungi is presented.
Results and discussion
In this work, several formulations based on combinations of
different IL based monomers (mIL) and cross-linkers were
investigated (Fig. 1A & B), with the aim of developing an opti-
mised ink composition for printing AgNP@PIL materials.
Initial 3D printing experiments used the digital light proces-
sing (DLP) technique, employing a Little RP printer with a DLP
projector to generate the UV light required for polymerisation.
Latter 3D printing experiments were performed with a newer
liquid crystal display (LCD) based printer (Elegoo Mars). The
latter allowed for marginally better resolution, and had a
smaller footprint, but no differences for the printing process
were noticed. The first tunable 3D printing ink formulation
was based on the polymerisable monomeric IL (mIL) precursor
1-butyl-3-vinylimidazolium bis(trifluoromethane)sulfonimide
([BVIM][NTf2]) (mIL1, Fig. 1A), which was synthesised from
1-butyl-3-vinylimidazolium bromide ([BVIM][Br]) via anion
metathesis as described in the ESI.† 34,35 mIL1 was chosen as
the polymerisable ionic liquid component as it has been pre-
viously demonstrated as a suitable poly(ionic liquid) (PIL) for
stabilising and solubilising hybrid organic–inorganic polyoxo-
metalates, and forms mechanically resistant polymers when
3D printed.34,35 Based on our previous experience, the initial
ink formulation (PIL1, Fig. 1B) consisted of mIL1 (80 mol%),
the crosslinker 1,4-butanediol diacrylate (20 mol%) and the
organic photoinitiator diphenyl(2,4,6-trimethylbenzoyl)phos-
phine oxide (TMDPO, 1 mol%) and was a clear, very pale
yellow viscous liquid. This ink composition was chosen as it
was previously found to be the most effective for 3D-printing
of PILs with the DLP technique. To this baseline formulation
silver hexafluoroantimonate (AgSbF6, ∼1 wt%) salt was solubil-
ised and stabilised.
The photopolymerisation of the PIL1 formulation resulted
in well-defined clear and very pale yellow PIL parts (Fig. 2A,
0 min). The pale-yellow colour of the 3D printed PIL1 pieces is
attributed to the polymer, thus suggesting that the encapsu-
lated silver was still in the Ag+ state, despite exposure to the
light during the 3D printing step. Furthermore, the UV-Visible
spectra of the as printed pieces confirmed the absence of an
absorption peak in the region λ ≈ 375–475 nm, attributable to
the LSPR band of the AgNPs (Fig. S1†),42 but does show the
expected absorption peak features for the photoinitiator
TMPDO.43 Then upon exposure to UV light, the photo-
reduction of Ag+ to Ag(0) was initiated and the colour of the
printed parts changed over time to increasingly darker shades
of amber (Fig. 2A), and TEM analysis confirmed the presence
of AgNPs (Fig. 2A, inset). The presence of Ag(0) was further
confirmed by XPS characterisation, which revealed the
expected peaks in the spectrum for Ag 3d3/2 and Ag 3d5/2
(Fig. S2A†).44 Indeed, the slight asymmetry of the Ag 3d5/2
peak toward higher binding energies could be due to a convo-
luted peak that corresponds to aggregated Ag nanoparticles,
which further corroborates the presence of AgNPs.45
Mechanical analysis of parts exposed to UV photoreduction
for different times indicated an increase in tensile stiffness
with increasing UV exposure time (Fig. S2B†). Additionally, the
corresponding tan ∂ vs. temperature curves revealed the Tg
values (defined as the x-axis values at each curve maximum)
also increased with increasing UV exposure time (Fig. 2B), the
secondary peak at low temperatures can be attributed to local
chain motions or side group movements in the polymer
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chains.46 The mechanical properties of the PIL1 pieces are
summarised in Fig. S2D.† FT-IR studies during UV exposure
over time revealed only a small decrease in the intensity of the
CvC stretch peak at ∼1660 cm−1 after 5 minutes of UV
exposure, and no further change upon further UV exposure
(Fig. 2C). The peak feature at ∼1660 cm−1 can also be attribu-
ted to the CvC bond in the imidazole ring,47–49 and thus the
intensity of this peak would not change upon further UV
exposure. Therefore, it is proposed that the increase in tensile
stiffness and Tg upon increased UV exposure time is due to the
continued formation of AgNPs and/or aggregation of AgNPs,
both of which contribute to modifying the mechanical pro-
perties of polymer matrices.50 UV-Vis transmission spec-
troscopy experiments during the UV post-printing treatment
further confirmed the formation of AgNPs due to the presence
of a shoulder peak centred at λ ≈ 450 nm increasing in absor-
bance, which is attributed to the AgNP plasmon. For compari-
son, an analogous liquid IL homogeneous system was pre-
pared, where Ag(SbF6) (1 wt%) was added to non-polymerisa-
ble 1-butyl-3-methylimidazolium bis(trifluoromethane)sulfoni-
mide and photo-reduced under UV light (λ = 395 nm). In this
case, the plasmon arising due to the presence of AgNPs, was
also observed as a shoulder in the UV-Vis spectrum (see
Fig. S3†). Interestingly, changing the monomer to 1-(3-hydroxy-
Fig. 1 This figure provides an overall visual summary of the work in this paper, and also shows the following specific results: (A) The components
employed for the development of the 3D printable PIL-based formulations; (B) table summarising the formulations explored and a qualitative assess-
ment of the properties of the materials developed. Unless indicated otherwise, 80 : 20 mol : mol, 1 mol% PI, 1 wt% AgSbF6; (C) example CAD design
that was employed as a benchmark for 3D-printing; (D) 3D-printed part with PIL3 formulation without Ag reduction; (E) 3D printed part with PIL3
formulation with AgNPs generated by post printing UV irradiation. Printed part; (F) the UV-Visible peak feature attributed to the AgNP plasmon in
3D-printed and UV-exposed PIL3 centred at 422 nm; and (G) transmission electron micrograph of a 3D printed and UV-exposed PIL3 part showing
the presence of AgNPs dispersed within the PIL matrix.
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[POHVIm][NTf2] (mIL2, Fig. 1B) in the formulation, whilst
keeping the rest of the formulation constant (PIL2), led to
better resolved plasmons after post-curing with a well-defined
plasmon (distinct absorption peak, rather than a shoulder
feature) with a maximum at λ = 413 nm (Fig. S4,† blue curve).
However, it was determined that LCD-based printing of the
PIL2 formulation resulted in excessively rigid samples, which
deformed and cracked during the polymerisation process. It
was hypothesised that the presence of the hydroxyl group of
the cation, combined with the use of 1,4-BDA as cross-linking
agent, had an influence on the mechanical properties of the
resulting material, which in turn affected the printability.
Instead, use of poly(ethyleneglycol) diacrylate (PEGDA, Mn =
575 g mol−1) resulted in much more flexible films (herein
PIL3, Fig. 1B), which showed suitable mechanical properties
for the polymerisation and 3D printing of suitable geometries
with acceptable resolution (Fig. 1C–E and Fig. S5†). The corres-
ponding UV-Visible peak feature attributable to AgNPs was
well-defined and centred at 422 nm (Fig. 1F and Fig. S4,† red
curve) and the AgNPs were well dispersed within the PIL
matrix (Fig. 1G). Now that a suitable composition of PIL ink
had been determined, aging experiments were performed to
determine the stability of the AgNP@PIL parts over time.
To examine the photostability of the AgNP@PIL materials,
PIL2 3D-printed parts were stored either under ambient light-
ing or in dark conditions. It was observed that AgNP@PIL2
materials, which had been generated by post-curing photore-
duction exhibited photo-aging when exposed to ambient light
in terms of an increase in the magnitude of the absorbance
peak attributed to AgNPs, suggesting the continued photore-
ductive formation of AgNPs (Fig. S6†). The stability of 3D-
printed AgSbF6-containing PILs to photoreduction was then
investigated and it was determined that storage in dark con-
ditions was required to prevent photo-aging. When non-photo-
reduced PIL2 pieces were exposed to three weeks of ambient
light a peak (centred at ∼450 nm) in the UV-Visible trans-
mission spectra developed, suggesting the formation of AgNPs
(Fig. 3A). In contrast, non-photoreduced 3D printed PIL2
pieces stored in the dark produced no such observable absor-
bance feature that could be attributed to AgNPs (Fig. 3B).
Thus, for use of these materials as potential antimicrobial
materials/devices, storage in dark conditions demonstrates the
hypothesis that it is possible to decouple the manufacturing of
devices by 3D printing from the photoreduction of active
AgNPs.
The presence of hydrophobic poly(ionic liquids) combined
with AgNPs make PILs interesting and highly applicable candi-
dates for antimicrobial surface coatings to prevent biofilm for-
mation. Ionic liquids are gaining relevance as they present
some desirable characteristics highly relevant in the clinical
use, such as improved bacterial resistance, antibiofilm pro-
perties, and the possibility of being 3D-printed as specific
dental objects, among others.41,51 The antimicrobial activity of
the PILs reported herein were evaluated against non-patho-
genic E. coli and B. subtilis and two moulds (A. niger and
Fig. 2 (A) The PIL1 3D printed parts exhibited different colours depending on the exposure time to UV light (λ = 395 nm, 36 W, r.t.) with (red inset) a
transmission electron micrograph showing the presence of nanoparticles; (B) The tan ∂ vs. temperature curves, where the Tg values (defined as the
x-axis values at each curve maximum) increase with increasing UV exposure time; and (C) FT-IR spectrum demonstrating little to no change in the
CvC peak upon increasing UV exposure time (the curve colours are the same as per the legend inset in (B). This suggests that further polymerisation
of unpolymerised CvC bonds in the materials is not contributing to the increases in tensile stiffness and Tg upon UV exposure.
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C. cladosporioides) via zone of inhibition (Kirby-Bauer) tests
and cell proliferation assays, as well as biofilm inhibition
studies. In general, PIL and AgNP@PIL samples act to inhibit
microbial growth, but AgNP-containing PILs (AgNP@PIL) are
more effective at reducing bacterial viability.
In the first instance, a zone of inhibition test of PIL1 and
AgNPs@PIL1 revealed that only the AgNP@PIL1 displayed an
inhibition halo against E. coli and B. subtilis (Fig. 4A). This
inhibition of bacterial growth around the sample is due to the
diffusion of the Ag+ ions into the agar, which is the most
important factor in the antimicrobial activity of the AgNPs
against bacteria.51 No inhibition halo was found with the PIL1
samples due to the lack of silver. A delay halo—characterised
for the mycelium growth but a lack of sporulation—was found
around AgNP@PIL1 incubated in the plate inoculated with
A. niger. No inhibition nor delay halo was found with the PIL1
sample, and neither PIL1 nor AgNP@PIL1 resulted in
mycelium or sporulation inhibition for C. cladosporioides
(Fig. 4B).
In order to determine the antibacterial activity of the
samples in solution, the bacterial growth in cell culture media
in the presence of the samples was monitored by optical
density. PIL1 repressed the growth of E. coli and B. subtilis in
liquid media over a 24 hour period but, interestingly, the
corresponding reduction in bacterial cell viability was lower
for the Gram-positive B. subtilis (Fig. 5A). Since hydrophobic
antimicrobial compounds often act by disrupting, depolar-
ising, and destabilising bacterial cell membranes,52,53 our
hypothesis was that the bacteriostatic PIL samples and the
associated stress to the cell membrane provokes increased pro-
liferation in this species. Furthermore, B. subtilis can form pro-
tective endospores that are able to tolerate harsh environ-
mental conditions, thus another hypothesis is that the pres-
ence of the PIL without silver can stimulate the production of
endospores by B. subtilis, potentially explaining the differences
compared with the growth of E. coli. This was confirmed by
Environmental Scanning Electron Microscopy (ESEM), which
showed a high degree of sporulation in B. subtilis (Fig. 5C). On
the other hand, the AgNPs@PIL1 variant was found to reduce
bacterial cell growth of E. coli and B. subtilis by 86% and 75%,
respectively, as expected, due to the antimicrobial effect of
silver. Broth and agar dilution methods are standard methods
used to determine the antimicrobial effect of the compounds,
but these assays are standardised for soluble compounds.
Hence, performing a surface antimicrobial assay is essential
when using compounds which are meant to be applied as a
coating or, like in this case, they are created directly as a 3D
object. Here, a modified Japanese Industrial Standard Z
2801 method was used to determine the surface antimicrobial
activity of PIL1 and AgNP@PIL1 (Table 1). PIL1 displayed a
bacterial reduction of 100% and 89% for E. coli and B. subtilis,
respectively, while AgNP@PIL1 reduced 100% of the bacterial
cell count. Subcultures of the supernatants confirmed the bac-
tericidal effect of the AgNP@PIL1, while PIL1 only displayed
bactericidal effect against E. coli. These results are commensu-
rate with the results in liquid medium and the ESEM images
(Fig. 5A), where the samples containing Ag displayed a higher
antimicrobial effect, with B. subtilis being the most resistant
strain. The differences in antimicrobial activity between the
solution and the surface activity tests show that the anti-
microbial properties are based primarily on surface contact-
Fig. 3 (A) AgNPs@PIL2 non-reduced and then aged under ambient light highlighting the development of a peak feature at ∼450 nm suggesting the
formation of AgNPs; and (B) AgNPs@PIL2 non-reduced and then aged under dark conditions, showing no AgNP plasmon. In all cases the samples
were exposed to ambient atmosphere.
Fig. 4 (A) Zone of Inhibition test of PIL1 and AgNPs@PIL1 against two
bacterial strains (E. coli and B. subtilis) and (B) two moulds (A. niger and
C. cladosporioides).
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killing rather than the release of an active component, such as
Ag+ ions, into the local environment.51 Evaluation of the anti-
bacterial activity of the PIL3 formulation yielded similar
results, however, AgNP@PIL3 was found to possess the highest
degree of inhibition after 24 hours of incubation, resulting in
a reduction of around 95% for both bacterial strains (Fig. 5B).
Conclusions
Herein, the capability of novel 3D-printed materials consisting
of polymeric ionic liquids (PILs) for the controlled on-demand
synthesis, and subsequent stabilisation, of silver nanoparticles
(AgNPs) has been demonstrated. It was determined that the
nature of the ionic liquid moieties affected the in situ for-
mation of the AgNPs and enabled the controlled formation
and stabilisation of AgNPs via extended UV photoreduction
after the 3D printing process. This demonstrated an effective
decoupling of the 3D printing fabrication step from the on-
demand generation of AgNPs with narrow size dispersity by
subsequent exposure to UV irradiation. Upon further investi-
gation, it was determined that the structure of the cation of
the monomer ionic liquid had a profound effect on the for-
mation of AgNPs, with a discrete UV-Vis peak feature attribu-
ted to the plasmon resonance of well-formed discrete AgNPs
within the PILs formed from mIL2 (AgNPs@PIL3), in contrast
to a broad shoulder feature measured in the UV-Vis spectrum
of AgNPs@PIL1. Thus, through careful choice of monomer
ionic liquid, a suitable crosslinker for favourable mechanical
properties, and a formulation that had previously been shown
to be effective for 3D printing, the fabrication of materials/
devices decoupled from on-demand photo-reductive formation
of AgNPs for enhanced antimicrobial activity was realised.
Indeed, the printed devices showed a multi-functional and
tuneable microbiocidal activity against Gram positive (B. subti-
lis) and Gram negative (E. coli) bacteria and against the fungus
A. niger. PIL-based materials were found to be bacteriostatic,
whereas AgNPs@PIL materials possessed enhanced anti-
microbial activity and bactericidal properties against the tested
strains.
This work represents the first example of the novel combi-
nation of the decoupled in situ photoreductive fabrication of
silver nanoparticles from the fabrication via 3D printing of the
PIL-based materials. This in situ generation of nanostructured
antimicrobial materials opens new routes to the development
of 3D printed devices resistant to biofilm formation, for appli-
cations in the biomedical, food technology and healthcare
industries. Furthermore, the near infinite combinations of
cations and anions possible in PIL-based materials allows for
further tuning and enhancement of the synergistic anti-
microbial properties, especially when combined with the
freedom of design inherent to additive manufacturing
techniques.
Fig. 5 (A) Bacterial cell viability of E. coli and B. subtilis incubated with PIL1 and AgNP@PIL1 and (B) PIL3 and AgNP@PIL3. (C) ESEM images of PIL1
and AgNP@PIL1 inoculated with E. coli and B. subtilis. Both PIL1 and AgNP@PIL1 affect E. coli morphology, disrupting the cell membrane. On the
other hand, PIL1 stimulates B. subtilis sporulation, while the AgNP@PIL1 prevents colonisation of the polymeric surface due to a higher bactericidal
effect.
Table 1 Bacterial reduction (%) after 24 hours incubation over the
samples
Bacterial reduction






























































































Unless otherwise stated, all reagents were purchased from
Sigma-Aldrich and used without further purification. BDA
(90%) and 1-vinylimidazole were used after purification by
passing through a short column of basic alumina (aluminium
oxide).
The 3D printers used in this study were a LittleRP 3D
printer and an Elegoo Mars. The Little RP 3D printer was
equipped with an Acer P1500 projector (3D printer light
source) that was fitted with an OSRAM P-VIP high pressure
(>200 bar) Hg vapour lamp (210 W). The Elegoo Mars printed
was equipped with a 2560 × 1440 2 K HD masking LCD, illumi-
nated with 40 W UV LED backlight (λ = 405 nm). The light
sources in both printers were both ∼3000 lumens. UV–vis
spectra were collected using an Agilent Cary 5000 UV–vis–NIR
spectrophotometer. FT-IR spectra were collected on a Bruker
Alpha fitted with a Platinum ATR module. 1H NMR spectra
were recorded on a Bruker AVX400 (400 MHz) spectrometer at
ambient temperature. 13C NMR spectra were recorded on a
Bruker AVX400 (101 MHz) spectrometer at ambient tempera-
ture. Environmental Scanning Electron Microscopy (ESEM)
data was collected on a Quanta FEG-250 (FEI Company) field
emission SEM for high-resolution imaging working in ESEM
mode using a GSED detector under high relative humidity con-
ditions. Transmission electron microscopy (TEM) measure-
ments were performed using a JEOL 2000-FX operated with an
accelerating voltage of 200 kV. The samples were prepared
using ultramicrotomy process, where sample slices of few
nanometres thickness were deposited on TEM grids. The
mechanical analyses were performed with a TA Q800 DMA
using a tension clamp. The moduli measurements as a func-
tion of temperature were measured using a strain amplitude of
0.1% and frequency of 1 Hz. The samples were cooled to
−50 °C and stabilised at −50 °C for 5 min. Finally, the sample
was then heated to 200 °C at the rate of 5 °C min−1. The
moduli were measured during the heating run. For the stress–
strain measurements, the samples were first equilibrated at
25 °C for 5 min and then the force was ramped from 0 to 18 N
at the rate of 1 N min−1 and the stress–strain curves were
recorded.
Synthesis of ionic liquids
Full synthesis details and characterisation data are given at the
end of the ESI.†
Process for 3D printing imidazolium PIL networks
The process for 3D printing imidazolium PIL pieces fabricated
with 80 mol% [BVIM][NTf2] (mIL1) ionic liquid is given as an
example. The stereolithography fabrication began by slicing a
3D computer aided design model into individual images for
projecting onto the photocurable ink. Additive manufacturing
software, Creation Workshop RC36, was used to create slices of
a desired thickness (50 μm per layer), control the projection
time of the images by the projector, and the movement of the
build plate of the LittleRP FlexVat. For the Elegoo Mars 3D
printer CHITUBOX software was employed. Then the printer
vat was filled with the premixed PIL1 ink, which contained
80 mol% [BVIM][NTf2], 20 mol% 1,4-butanediol diacrylate
(BDA), 1 mol% diphenyl(2,4,6-trimethylbenzoyl)phosphine
oxide (photoinitiator) and 1 wt% silver hexafluoroantimonate
(AgSbF6). Then the build plate was lowered into the ink against
the transparent film of the bottom of the vat. The software
then controlled the projector to show a black background with
white images of each of the layers which were to be photo-
cured. The UV light passed through the transparent bottom of
the vat. Each layer (50 μm) was cured for 8 s. After 8 s, the
printer showed a black background (negligible light was pro-
jected into the photocurable ink) whilst the build plate was
automatically lifted by 50 μm. Then the software loaded the
image of the next layer and turned “on” the UV light by
showing the next white colour image. This process was
repeated until the object was completely fabricated. After the
object was fabricated, the object was isolated and copiously
washed with isopropyl alcohol to remove any uncured ink.
UV–Vis absorbance measurements of 3D-printed pieces
For collection of the UV–vis absorbance spectra of the 3D
printed specimen, before and after irradiation with UV light,
the specimen was first affixed to a metal holder exposed to UV
light for a determined fixed amount of time, then a UV–vis
spectrum of this specimen was collected using the Cary 5000
UV–vis–NIR spectrophotometer. Once the UV-Vis spectrum
was collected, the procedure was repeated until a total UV light
exposure of the desired time was reached.
Microorganisms and growth conditions
Two bacterial strains were tested in the antibacterial assays:
Escherichia coli DH5α as a Gram-negative model and Bacillus
subtilis 1904-E as a Gram-positive model. Two moulds from
the “Colección Española de Cultivos Tipo (CECT)” were tested
in the antifungal assays: Aspergillus niger CECT 2088 and
Cladosporium cladosporioides CECT 2111. Fungal spore suspen-
sions were stored in 0.1% Tween, 20% glycerol at −80 °C prior
to use. The following culture media was used: Tryptone Soy
Agar (TSA) (Thermo Scientific™), Sabouraud Dextrose Agar
supplemented with chloramphenicol (SDA) (Scharlab, S. L.), as
solid media; Luria–Bertani (LB) and Nutrient Broth (NB)
(Scharlab, S. L.) as liquid media. The microbial growth con-
ditions are summarised in the Table 2.
Agar diffusion test
A modified Kirby Bauer disk diffusion technique was used.
The 3D printed samples (3 mm-diameter circles of PIL and
AgNPs@PIL) were first sterilised with ethanol 70% and then
they were placed in solid media previously inoculated with a
bacterial lawn (107 CFU mL−1) of E. coli or B. subtilis. After
24 hours of incubation at 37 °C, the inhibition halo around
the samples was observed.
For the antifungal assay, the 3D printed samples (20 mm-
diameter circles of PIL and AgNPs@PIL) were sterilised with
Biomaterials Science Communication
























































































ethanol 70% and then placed in solid media previously inocu-
lated with a spore solution (104 conidia mL−1) of A. niger or
C. cladosporioides. After 96 hours of incubation at the corres-
ponding temperature (see Table 2), the inhibition halo around
the samples was observed.
Bacterial cell proliferation assay
Bacterial growth was recorded measuring the optical density
(OD) of the samples at 600 nm over a 24 hour period using a
microplate reader (Thermo Scientific MULTISKAN GO). Results
were compared with the OD variation of a control culture con-
taining only E. coli or B. subtilis. The data for all control experi-
ments and antibacterial assays are based on a total of six
repeats to verify the reproducibility of the results and to calcu-
late the mean values and the standard deviation; each experi-
ment was repeated a minimum of three times to verify the
results between different inoculations. The samples (PIL and
AgNPs@PIL), previously sterilised with ethanol 70%, were
placed in a 24-well plate inoculated with 1 mL of the inoculum
(1 × 107 CFU mL−1 of E. coli or B. subtilis), incubated at 37 °C,
and the antiproliferative effects induced by the samples were
observed by plotting optical density (OD) vs. time. Bacterial
growth was recorded measuring the optical density (OD) of
100 µL collected from each well of the 24-well plate, in a
96-well plate. Measurements at 600 nm were performed using
a microplate reader, each hour during the first 8 hours and at
24 hours as a final point. To maintain the final volume (1 mL)
during the experiment, the 100 µL subtracted from the wells
from the 24-well plate were replaced with 100 µL of medium.
Results were compared with the OD variation of a control
culture containing only bacteria (E. coli or B. subtilis).
Statistical analysis was performed using unpaired t-test. P
values <0.05 were considered significant. Single stars denote
0.01 < P < 0.05.
Surface antimicrobial activity
The surface antimicrobial activity was studied using a modi-
fied JIS Z 2801 standard. The protocol lasts three days. On the
first day, a bacterial suspension of 1 × 107 CFU mL−1 was pre-
pared and then 50 µL of this suspension was added over the
surface of the samples of interest (2 × 2 cm) and over a refer-
ence sample with no antimicrobial activity (2 × 2 cm) after the
sterilisation of these samples with ethanol 70%. In order to
even the contact surface, a coverslip was put above the 50 µL of
bacterial suspension in all the samples. The samples were
incubated in a humid chamber at 37 °C for 24 h. After the 24 h
of incubation, the bacteria over the samples were extracted
into liquid medium by putting the samples into a 50 ml falcon
with 15 mL of culture media and shaking them one minute
with a vortex. The culture media with the extracted bacteria
was then diluted and sown in agar plates, which were incu-
bated at 37 °C during 24 h. On the last day, the CFU of the cul-
tivated agar plates were counted. The percentage of bacterial
log reduction was obtained using the following formula:
Reduction ¼ logðcfu reference sampleÞ
 logðcfu antimicrobial sampleÞ
Environmental scanning electron microscopy (ESEM) of the
bacteria incubated over the samples
The effect of the samples (PIL and PIL@AgNPs) on the mor-
phology of the bacteria was studied by ESEM. The samples
were sterilised with ethanol 70% and inoculated with 100 μL
of a 104 CFU mL−1 bacterial suspension. Then the inoculated
samples were incubated in a humid chamber at 37 °C for 24 h.
After the incubation time, the samples were rinsed with dis-
tilled sterile water and visualised on a Quanta FEG-250 (FEI
Company) field emission SEM for high-resolution imaging
working in ESEM mode using a GSED detector.
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Table 2 Microorganisms and growth conditions
Microorganism Solid medium Liquid medium Incubation temperature (°C) Pre-inoculum incubation
Bacteria E. coli DH5α TSA LB 37 24 hours
B. subtilis TSA NB 37 24 hours
Fungi A. niger SDA — 35 4 days
C. cladosporioides SDA — 25 4 days
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